More news
-
Experts evaluate treatment of PAH in the sotatercept era
Zeenat Safdar, MD, FCCP, reviewed recent clinical trial data on the use of the activin-signaling inhibitor sotatercept in pulmonary arterial hypertension (PAH).
-
Clinician leaders share business world lessons for health care teams
CHEST President-Elect Neil Freedman, MD, FCCP, discussed how traditional business administration skills translate to leadership and professional growth in health care.
-
University at Buffalo wins CHEST Challenge Championship in Chicago
The first-place team of Rishabh Bansal, MBBS; Jessica Baek, MD; and Yu-Che Lee, MD, MPH, competed against fellows from the University of Colorado and Marshall University during the annual clinical trivia event at CHEST 2025.
